AbbVie: Growth Is Still A Better Choice (NYSE:ABBV)

Since my last article was published on April 29, AbbVie’s share price (NYSE:ABBV) has risen more than 16%, hitting new multi-year highs.

This article will focus not only on the company’s Q2 2024 financial results but also on other factors

Read the full article here